Issuer · CIK 0001672619
ELVN — Enliven Therapeutics, Inc.
Recent filings
- Jul 21, 2026·Form 4·Sell$140.8K
ELVN/Enliven Therapeutics, Inc.
Hohl Benjamin · CHIEF FINANCIAL OFFICER
Mechanical filing
AI thesis skipped - Jul 21, 2026·Form 4·Sell$116.7K
ELVN/Enliven Therapeutics, Inc.
Collins Helen Louise · CHIEF MEDICAL OFFICER
Mechanical filing
AI thesis skipped - Jun 24, 2026·Form 4·Sell$35.7M
ELVN/Enliven Therapeutics, Inc.
ORBIMED ADVISORS LLC · director
Mechanical filing
AI thesis skipped - Jun 22, 2026·Form 4·Sell$149.2K
ELVN/Enliven Therapeutics, Inc.
Hohl Benjamin · CHIEF FINANCIAL OFFICER
12conviction - Jun 22, 2026·Form 4·Sell$114K
ELVN/Enliven Therapeutics, Inc.
Collins Helen Louise · CHIEF MEDICAL OFFICER
Mechanical filing
AI thesis skipped - Jun 17, 2026·Form 4·Sell$12.3M
ELVN/Enliven Therapeutics, Inc.
ORBIMED ADVISORS LLC · director
Mechanical filing
AI thesis skipped - Jun 9, 2026·Form 4·Sell$266.7K
ELVN/Enliven Therapeutics, Inc.
Kunkel Lori Anne · director
Mechanical filing
AI thesis skipped - May 20, 2026·Form 4·Sell$137.4K
ELVN/Enliven Therapeutics, Inc.
Collins Helen Louise · CHIEF MEDICAL OFFICER
Mechanical filing
AI thesis skipped - Feb 17, 2026·Form 4·Other—
ELVN/Enliven Therapeutics, Inc.
Heyman Richard A. · director
Mechanical filing
AI thesis skipped